Winthrop Capital Management’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
Winthrop Capital Management's PFE Position: Q3 2026 in Review
Winthrop Capital Management reduced its Pfizer (PFE) stake by 9.6% in Q3 2026, selling an estimated $32.4K and leaving 11,442 shares worth $326K. The position accounts for 0.08% of the portfolio, ranked #100.
Winthrop Capital Management first reported a position in PFE in Q4 2023 and has held it in 9 quarters since. The position peaked at $861K in Q4 2024. 2,908 funds tracked by Wall St. Rank hold PFE as of Q3 2026.
- Winthrop Capital Management held 11,442 shares of Pfizer worth $326K as of Q3 2026.
- Winthrop Capital Management sold 1,218 Pfizer shares in Q3 2026, an estimated $32.4K.
- Pfizer made up 0.08% of Winthrop Capital Management's portfolio in Q3 2026, its #100 holding.
- Winthrop Capital Management first reported a position in Pfizer in Q4 2023 and has held it in 9 quarters since.
- Winthrop Capital Management's Pfizer position peaked at $861K in Q4 2024.
- 2,908 funds tracked by Wall St. Rank held Pfizer as of Q3 2026.
Based on Winthrop Capital Management's 13F filing for Q3 2026, filed 5 Nov 2026.